A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : VLCFA / very long chain fatty acids

[Related PubMed/MEDLINE]
Total Number of Papers: 369
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   VLCFA  (>> Co-occurring Abbreviation)
Long Form:   very long chain fatty acids
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 A 29-year-old patient with adrenoleukodystrophy presenting with Addison's disease. ALD, MRI
2020 Characterization of a Pathogenic Variant in the ABCD1 Gene Through Protein Molecular Modeling. ABCD1, AMN, X-ALD
2020 Hexacosenoyl-CoA is the most abundant very long-chain acyl-CoA in ATP-binding cassette transporter D1-deficient cells. ABCD1, CoA, X-ALD
2020 Mild Zellweger syndrome due to functionally confirmed novel PEX1 variants. MR, ZSD
2020 Spastic paraplegia as the predominant phenotype in a cohort of Chinese patients with adrenoleukodystrophy. ALD, HSP
2020 X-linked adrenoleukodystrophy: Pathology, pathophysiology, diagnostic testing, newborn screening and therapies. ALD
2019 A microglial cell model for acyl-CoA oxidase 1 deficiency. ACOX1, TREM2
2019 Application of machine learning algorithms for the differential diagnosis of peroxisomal disorders. AUC, RCDP, X-ALD, ZS
2019 Characterization of very long chain fatty acid synthesis inhibition by ipfencarbazone. VLCFAE
10  2019 Chinese patients with adrenoleukodystrophy and Zellweger spectrum disorder presenting with hereditary spastic paraplegia. ALD, HSP, ZSD
11  2019 Clinical, neuroimaging, biochemical, and genetic features in six Chinese patients with Adrenomyeloneuropathy. X-ALD
12  2019 CRISPR/Cas9-mediated knockout of Abcd1 and Abcd2 genes in BV-2 cells: novel microglial models for X-linked Adrenoleukodystrophy. X-ALD
13  2019 Genome-wide characterization and expression of the elongation of very long chain fatty acid (Elovl) genes and fatty acid profiles in the alga (Tetraselmis suecica) fed marine rotifer Brachionus koreanus. FA
14  2019 Late onset adrenoleukodystrophy: A review related clinical case report. ---
15  2019 Natural history of a cohort of ABCD1 variant female carriers. AACS, ABCD1, X-ALD
16  2019 PUCHI regulates very long chain fatty acid biosynthesis during lateral root and callus formation. ---
17  2019 The impact of reducing fatty acid desaturation on the composition and thermal stability of rapeseed oil. HOLP, PUFAs
18  2019 Thermogenic flux induced by lignoceric acid in peroxisomes isolated from HepG2 cells and from X-adrenoleukodystrophy and control fibroblasts. FA, X-ALD
19  2019 X-linked adrenoleukodystrophy diagnosed in three brothers. HSCT
20  2019 X-linked Adrenoleukodystrophy: Pathology, Pathophysiology, Diagnostic Testing, Newborn Screening, and Therapies. ALD
21  2018 Dietary rescue of lipotoxicity-induced mitochondrial damage in Peroxin19 mutants. Lip3, MCFAs, PBDs, PEX
22  2018 Effect of Lorenzo's Oil on Hepatic Gene Expression and the Serum Fatty Acid Level in abcd1-Deficient Mice. ALD
23  2018 Etiology and treatment of adrenoleukodystrophy: new insights from Drosophila. ALD, bgm, dbb
24  2018 Induction of peroxisomal changes in oligodendrocytes treated with 7-ketocholesterol: Attenuation by alpha-tocopherol. 7-KC
25  2018 Inflammatory profile in X-linked adrenoleukodystrophy patients: Understanding disease progression. X-ALD
26  2018 MYB30 links ROS signaling, root cell elongation, and plant immune responses. ROS
27  2018 Oleoylethanolamide treatment reduces neurobehavioral deficits and brain pathology in a mouse model of Gulf War Illness. GW, GWI, OEA
28  2018 Profiling and Imaging of Phospholipids in Brains of Abcd1-Deficient Mice. X-ALD
29  2018 Prospective Associations of Erythrocyte Composition and Dietary Intake of n-3 and n-6 PUFA with Measures of Cognitive Function. ARA, MMSE, PUFA
30  2018 Spastic paraparesis caused by X-linked adrenoleukodystrophy mimicking vacuolar myelopathy in a human immunodeficiency virus patient: A case report. HIV, MRI, X-ALD
31  2018 Sphingolipidomics of Thermotolerant Yeasts. InsP, LCB, MInsPCer, PtdInsCer
32  2018 Transcriptomic and Metabolomic Reprogramming from Roots to Haustoria in the Parasitic Plant, Thesium chinense. ---
33  2018 [Peroxisomal disorders]. ---
34  2017 A link between very long chain fatty acid elongation and mating-specific yeast cell cycle arrest. ---
35  2017 A zebrafish model of X-linked adrenoleukodystrophy recapitulates key disease features and demonstrates a developmental requirement for abcd1 in oligodendrocyte patterning and myelination. ALD
36  2017 Application of a diagnostic methodology by quantification of 26:0 lysophosphatidylcholine in dried blood spots for Japanese newborn screening of X-linked adrenoleukodystrophy. cALD, lysoPC, X-ALD
37  2017 Biochemical and clinical profiles of 52 Tunisian patients affected by Zellweger syndrome. ZS
38  2017 Comparison of C26:0-carnitine and C26:0-lysophosphatidylcholine as diagnostic markers in dried blood spots from newborns and patients with adrenoleukodystrophy. ALD
39  2017 Engineering Rhodosporidium toruloides for the production of very long-chain monounsaturated fatty acid-rich oils. ---
40  2017 Evaluation of C26:0-lysophosphatidylcholine and C26:0-carnitine as diagnostic markers for Zellweger spectrum disorders. DBS, ZSD
41  2017 HIF-1alpha:CRAT:miR-144-3p axis dysregulation promotes osteoarthritis chondrocyte apoptosis and VLCFA accumulation. ---
42  2017 Identification and Characterization of Phospholipids with Very Long Chain Fatty Acids in Brewer's Yeast. FA
43  2017 Lipid-induced endoplasmic reticulum stress in X-linked adrenoleukodystrophy. ALD
44  2017 Long-term outcome of patients with X-linked adrenoleukodystrophy: A retrospective cohort study. AMN, CCALD, HSCT, X-ALD
45  2017 Metabolic engineering of Saccharomyces cerevisiae for production of very long chain fatty acid-derived chemicals. ---
46  2017 Method for Measurement of Peroxisomal Very Long-Chain Fatty Acid Beta-Oxidation and De Novo C26:0 Synthesis Activity in Living Cells Using Stable-Isotope Labeled Docosanoic Acid. ---
47  2017 Overexpression of the Novel Arabidopsis Gene At5g02890 Alters Inflorescence Stem Wax Composition and Affects Phytohormone Homeostasis. ABA, ER, JA, JA-Ile
48  2017 Tauroursodeoxycholic bile acid arrests axonal degeneration by inhibiting the unfolded protein response in X-linked adrenoleukodystrophy. AD, ALS, ER, PD, TUDCA, UPR, X-ALD
49  2017 The Lipopolysaccharide Lipid A Long-Chain Fatty Acid Is Important for Rhizobium leguminosarum Growth and Stress Adaptation in Free-Living and Nodule Environments. LPS
50  2017 The Very Long Chain Fatty Acid (C26:25OH) Linked to the Lipid A Is Important for the Fitness of the Photosynthetic Bradyrhizobium Strain ORS278 and the Establishment of a Successful Symbiosis with Aeschynomene Legumes. ---
51  2017 X-linked adrenoleukodystrophy in a chimpanzee due to an ABCD1 mutation reported in multiple unrelated humans. AMN, X-ALD
52  2016 25-hydroxycholesterol contributes to cerebral inflammation of X-linked adrenoleukodystrophy through activation of the NLRP3 inflammasome. 25-HC, CCALD, CH25H, LXR, ROS, X-ALD
53  2016 ABC Transporter Subfamily D: Distinct Differences in Behavior between ABCD1-3 and ABCD4 in Subcellular Localization, Function, and Human Disease. ABC
54  2016 Absence of biochemical evidence at an early age delays diagnosis in a patient with a clinically severe peroxisomal biogenesis disorder. ---
55  2016 C26:0-Carnitine Is a New Biomarker for X-Linked Adrenoleukodystrophy in Mice and Man. ALD
56  2016 Characterization of the role of sphingomyelin synthase 2 in glucose metabolism in whole-body and peripheral tissues in mice. KO, SMS2, WT
57  2016 CYP4F2 affects phenotypic outcome in adrenoleukodystrophy by modulating the clearance of very long-chain fatty acids. ALD
58  2016 Endocrine Dysfunction in X-Linked Adrenoleukodystrophy. X-ALD
59  2016 Familial risk for bipolar disorder is not associated with impaired peroxisomal function: Dissociation from docosahexaenoic acid deficits. ---
60  2016 Genome-scale analysis of the cotton KCS gene family revealed a binary mode of action for gibberellin A regulated fiber growth. CesA, GAREs, KCS
61  2016 Infantile Refsum Disease: Influence of Dietary Treatment on Plasma Phytanic Acid Levels. IRD, ZSDs
62  2016 Localization of the Transpiration Barrier in the Epi- and Intracuticular Waxes of Eight Plant Species: Water Transport Resistances Are Associated with Fatty Acyl Rather Than Alicyclic Components. ---
63  2016 Novel Therapeutic Targets and Drug Candidates for Modifying Disease Progression in Adrenoleukodystrophy. X-ALD
64  2016 Pathogenicity of novel ABCD1 variants: The need for biochemical testing in the era of advanced genetics. ALD
65  2016 Phenotypic variability in a Tunisian family with X-linked adrenoleukodystrophy caused by the p.Gln316Pro novel mutation. ---
66  2016 Proline Coordination with Fatty Acid Synthesis and Redox Metabolism of Chloroplast and Mitochondria. CYP86A2, DPI, LACS2, PDH1, Pro
67  2016 Structural characterization of suppressor lipids by high-resolution mass spectrometry. PI, PIM, PIMIP
68  2015 A novel ABCD1 mutation detected by next generation sequencing in presumed hereditary spastic paraplegia: A 30-year diagnostic delay caused by misleading biochemical findings. ALD, AMN, HSP, NGS
69  2015 ABCD1 deletion-induced mitochondrial dysfunction is corrected by SAHA: implication for adrenoleukodystrophy. ABCD1, ALDP, SAHA, X-ALD
70  2015 Adenoassociated virus serotype 9-mediated gene therapy for x-linked adrenoleukodystrophy. ABCD1, CNS, i.c.v, rAAV9, X-ALD
71  2015 Arabidopsis acyl-CoA-binding protein ACBP3 participates in plant response to hypoxia by modulating very-long-chain fatty acid metabolism. ACBP3-OEs, ACBPs
72  2015 Astrocytes and mitochondria from adrenoleukodystrophy protein (ABCD1)-deficient mice reveal that the adrenoleukodystrophy-associated very long-chain fatty acids target several cellular energy-dependent functions. X-ALD
73  2015 Brain microsomal fatty acid elongation is increased in abcd1-deficient mouse during active myelination phase. NEM, WT
74  2015 Enzymatic characterization of ELOVL1, a key enzyme in very long-chain fatty acid synthesis. X-ALD
75  2015 Histological analyses by matrix-assisted laser desorption/ionization-imaging mass spectrometry reveal differential localization of sphingomyelin molecular species regulated by particular ceramide synthase in mouse brains. Cer, CerS, IMS, SM, SMS
76  2015 Metabolic dysfunctions in multiple sclerosis: implications as to causation, early detection, and treatment, a case control study. GTAs, MS, PlsEtn, PPMS, PtdEtn, RRMS
77  2015 Metabolic engineering of oilseed crops to produce high levels of novel acetyl glyceride oils with reduced viscosity, freezing point and calorific value. acetyl-TAGs, EaDAcT, TAG
78  2015 Oxidative stress, mitochondrial and proteostasis malfunction in adrenoleukodystrophy: A paradigm for axonal degeneration. AD, PD
79  2015 Quantitative proteomics and transcriptomics reveal key metabolic processes associated with cotton fiber initiation. ---
80  2015 Regulation of FATTY ACID ELONGATION1 expression in embryonic and vascular tissues of Brassica napus. ---
81  2015 Role of family D ATP-binding cassette transporters (ABCD) in cancer. ABC, ABCD, X-ALD
82  2015 Rom2-dependent phosphorylation of Elo2 controls the abundance of very long-chain fatty acids. ---
83  2015 Violent death in a rare peroxisomal disease--Zellweger syndrome. ---
84  2014 A Korean boy with atypical X-linked adrenoleukodystrophy confirmed by an unpublished mutation of ABCD1. PCR, X-ALD
85  2014 Abcd2 is a strong modifier of the metabolic impairments in peritoneal macrophages of ABCD1-deficient mice. ABC, MPMPhi, X-ALD
86  2014 Adrenomyeloneuropathy with bulbar palsy: A rare association. ALD, AMN
87  2014 Enteric YaiW is a surface-exposed outer membrane lipoprotein that affects sensitivity to an antimicrobial peptide. ---
88  2014 Mitochondrial dysfunction and oxidative damage cooperatively fuel axonal degeneration in X-linked adrenoleukodystrophy. X-ALD
89  2014 Monitoring of very long-chain fatty acids levels in X-linked adrenoleukodystrophy, treated with haematopoietic stem cell transplantation and Lorenzo's Oil. HSCT
90  2014 PAG1, a cotton brassinosteroid catabolism gene, modulates fiber elongation. BL, BRs, pag1
91  2014 Reductions in neuronal peroxisomes in multiple sclerosis grey matter. GAPDH, GM, MS
92  2014 Uridine prevents fenofibrate-induced fatty liver. ACOX1, LCFA
93  2014 Very-long-chain polyunsaturated fatty acids accumulate in phosphatidylcholine of fibroblasts from patients with Zellweger syndrome and acyl-CoA oxidase1 deficiency. DBP, VLCPUFA, X-ALD, ZS
94  2013 Adrenomyeloneuropathy presenting with adrenal insufficiency. ALD, AMN
95  2013 Caffeic acid phenethyl ester induces adrenoleukodystrophy (Abcd2) gene in human X-ALD fibroblasts and inhibits the proinflammatory response in Abcd1/2 silenced mouse primary astrocytes. CAPE, X-ALD
96  2013 Child neurology: Zellweger syndrome. ZS
97  2013 Evolutionary pattern of the FAE1 gene in brassicaceae and its correlation with the erucic acid trait. FAE1
98  2013 Exome sequencing released a case of X-linked adrenoleukodystrophy mimicking recessive hereditary spastic paraplegia. HSP
99  2013 Histone deacetylase inhibitor upregulates peroxisomal fatty acid oxidation and inhibits apoptotic cell death in abcd1-deficient glial cells. ELOVLs, HDAC, SAHA, X-ALD
100  2013 Involvement of Arabidopsis ACYL-COENZYME A DESATURASE-LIKE2 (At2g31360) in the biosynthesis of the very-long-chain monounsaturated fatty acid components of membrane lipids. CoA